|Immunotherapeutic Strategies in RRMM: Differentiating Between Emerging Approaches|
Irene Ghobrial, MD
|Release Date: March 05, 2020|
Expiration Date: March 05, 2021
In support of the community oncology practitioner, this activity provides the most up-to-date advances and strategies for treating relapsed/refractory myeloma while supporting the translation of this information into practice through provision of applied clinical tools and resources.Provided by MediCom Worldwide, Inc.
This activity is supported by an educational grant from Celgene Corporation.
|Begin, Earn CreditView Only, No Credit|